Clinical Trial Update: PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System [NA]

View source ↗

Summary

The PROMISE I early feasibility trial evaluated the LimFlow Stent Graft System for critical limb ischemia and chronic limb-threatening ischemia; the trial is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Limb-threatening Ischemia

Drugs mentioned

• LimFlow Stent Graft System

Snippet

Sponsor: LimFlow, Inc. | Conditions: Critical Limb Ischemia, Chronic Limb-Threatening Ischemia | NA | Status: COMPLETED | Results posted: 2024-05-21